The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.
Receiving a non-melanoma skin cancer diagnosis can feel stressful. In fact, studies show that more than one in three patients find the diagnosis traumatic, with many more experiencing anxiety about what comes next. For many,…
BOCA RATON, Fla., Sept. 21, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise in full of the underwriters’…
Dr. Ellen Turner discusses with CEO Money host, Michael Yorba, the non-invasive and pain free benefits of treating skin cancer with Superficial Radio Therapy. With Dr. Turner’s two dermatology practice locations in the Dallas area,…
BOCA RATON, Fla., Sept. 17, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it completed a public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at a public…
BOCA RATON, Fla., Sept. 13, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock, par value $0.01 per share, at…
